Alexander COVID News evidence-based medicine convoy mandate

Share this post
Pfizer's Paxlovid can be very dangerous, be warned: could cause severe or life-threatening interactions with widely used medications, including statins, blood thinners and some antidepressants.
palexander.substack.com

Pfizer's Paxlovid can be very dangerous, be warned: could cause severe or life-threatening interactions with widely used medications, including statins, blood thinners and some antidepressants.

This drug and the other Molnupiravir (MONEYpiravir) were not studied properly and based on 1 study each, while FDA et al. discredits IVM and HCQ based on hundreds of studies.

Dr. Paul Alexander
May 2
Comment17
Share

Paxlovid

“The Food and Drug Administration authorized Pfizer’s Paxlovid for mild to moderate Covid in people as young as 12 who have underlying conditions that raise the risk of hospitalization and death from the coronavirus, such as heart disease or diabetes. However, one of the two drugs in the antiviral cocktail could cause severe or life-threatening interactions with widely used medications, including statins, blood thinners and some antidepressants. And the FDA does not recommend Paxlovid for people with severe kidney or liver disease.”

Comment17
ShareShare

Create your profile

0 subscriptions will be displayed on your profile (edit)

Skip for now

Only paid subscribers can comment on this post

Already a paid subscriber? Sign in

Check your email

For your security, we need to re-authenticate you.

Click the link we sent to , or click here to sign in.

Eric
Writes The Imaginary Hobgoblin ·May 2

Pfzier and the FDA are nothing less than criminal organizations who are only interested in lining their pockets rather than dispensing quality healthcare. Preying on people who have no critical thinking or objective reasoning skills is not a virtue.

Expand full comment
ReplyGive gift
1 reply
Elizabeth HW
May 2

I cringe every time I see their commercials....

Expand full comment
ReplyGive gift
1 reply
15 more comments…
TopNewCommunity

No posts

Ready for more?

© 2022 Paul
Privacy ∙ Terms ∙ Collection notice
Publish on Substack Get the app
Substack is the home for great writing